# Antibody and Delayed Cyclosporine Versus Initial Cyclosporine Alone in Patients Receiving Kidney Transplants

> **NCT00007787** · NA · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 350 (estimated)

## Conditions studied

- Kidney Transplantation
- Chronic Allograft Nephropathy

## Interventions

- **BIOLOGICAL:** Cyclosporine
- **BIOLOGICAL:** Anti-human thymocyte globulin (rabbit)
- **DRUG:** Tacrolimus

## Key facts

- **NCT ID:** NCT00007787
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-04
- **Primary completion:** —
- **Final completion:** 2004-03
- **Target enrollment:** 350 (ESTIMATED)
- **Last updated:** 2013-01-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00007787

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00007787, "Antibody and Delayed Cyclosporine Versus Initial Cyclosporine Alone in Patients Receiving Kidney Transplants". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT00007787. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*